AIxCrypto Holdings, Inc.
AIXCCIK 0001460702 · Finance Services · Nasdaq
- Qualigen Therapeutics, Inc. (until 2025-11-19)
- RITTER PHARMACEUTICALS INC (until 2020-05-20)
Revenue (TTM)
$6.11M
−11.9% YoY
Q1 May 2026
Net Income (TTM)
−$12.45M
−171.1% YoY
Q1 May 2026
EPS Diluted (TTM)
−$8.29
+53.8% YoY
Q1 May 2026
Gross Margin
11.3%
Q1 May 2026
Operating Margin
-166.6%
Q1 May 2026
Net Margin
-203.9%
Q1 May 2026
Free Cash Flow (TTM)
−$9.92M
Q1 May 2026
Cash
$6.2M
Q1 May 2026
Total Debt
$3.02M
Q1 May 2026
Shares Outstanding
20.23M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
Balance Sheet
Cash vs Debt
Latest news
All news →-
High Negative
AIxCrypto Holdings (AIXC) Signs VWAP Share Purchase Agreement
AIxCrypto Holdings entered a committed equity facility letting an investor buy shares at a 7% discount to market price, with a 3% transaction fee retained by th...